Reduced spinal inhibition as indicated by reduced immunopositivity for GABAergic neurons or GAD65/67 enzyme, together with electrophysiological recordings, has been described in several models of neuropathic pain (37, 57–62). This evidence concerns the gene GAD2 and neuropathic pain.